Skip to main content
DIACEUTICS PLC logo

DIACEUTICS PLC — Investor Relations & Filings

Ticker · DXRX ISIN · GB00BJQTGV64 LEI · 213800VEWQBB39ZB8J81 IL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 278 across all filing types
Latest filing 2021-05-21 Major Shareholding Noti…
Country GB United Kingdom
Listing IL DXRX

About DIACEUTICS PLC

https://www.diaceutics.com/

Diaceutics PLC is a data analytics and end-to-end services provider focused on the development and commercialization of precision medicine diagnostics. The company supports pharmaceutical and biotech clients by providing solutions to improve the diagnostic testing ecosystem, aiming to ensure patients receive the correct personalized treatment. Its primary offering is DXRX, The Diagnostic Network®, a diagnostic commercialization platform for precision medicine. DXRX facilitates collaboration among stakeholders, including laboratories and pharmaceutical companies, in a secure marketplace and provides access to real-world diagnostic testing data. This integrated platform is designed to streamline the launch and adoption of new precision medicines.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly identified as an 'RNS Number' filing from 'Diaceutics PLC' dated '21 May 2021'. The content is structured as 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the classification over the general RNS fallback.
2021-05-21 English
Change of Adviser
Board/Management Information Classification · 99% confidence The document is a short announcement (3033 characters) disseminated via RNS (Regulatory News Service) of the London Stock Exchange. The content explicitly states an immediate change in the company's Nominated Adviser and Sole Corporate Broker. This type of corporate action announcement, which is not a full financial report (like 10-K or IR) or a specific management/director change, fits best under the general category for regulatory announcements that do not fit elsewhere, or potentially a specific corporate action. Since it announces a change in professional representation (Nominated Adviser), it is a significant regulatory update. Given the structure (RNS Number, date, brief announcement, contact details, and RNS footer), it is a standard regulatory filing. While it involves management/advisors, the core function is a regulatory notification. The most appropriate general category for such a brief, official regulatory update that isn't explicitly covered by MANG (Board/Management change) or DIRS (Director dealing) is RNS (Regulatory Filings) or potentially LTR (Legal Proceedings Report) if the change was due to regulatory issues, but here it seems routine. Given the source (RNS Number) and the nature of the announcement (change of adviser), RNS is the best fit as a general regulatory filing.
2021-05-21 English
Result of AGM
AGM Information Classification · 99% confidence The document explicitly states 'Results of Annual General Meeting' and provides a detailed table showing the 'proxy votes received from shareholders in respect of each resolution' passed at the AGM. This directly corresponds to the definition of AGM Information (AGM-R). Although it contains voting results (DVA), the primary purpose and context of the entire announcement is reporting the outcome of the Annual General Meeting itself, making AGM-R the most specific and accurate classification.
2021-05-19 English
LGC SeraCare Partnership
Regulatory Filings Classification · 100% confidence The document begins with an 'RNS Number' and is dated May 13, 2021. The content describes a new partnership between Diaceutics PLC and LGC SeraCare regarding diagnostic commercialization solutions and the DXRX platform. It includes quotes from executives and contact information for advisors. Crucially, the footer explicitly states: 'This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange,' and 'Reach announcements are identified with an orange label and the word “Reach” in the source column... so that they are distinguished from the RNS UK regulatory service.' Since this is a press release announcing a business development (partnership) and is explicitly marked as non-regulatory news distributed via the RNS system (Reach service), it does not fit the specific categories like 10-K, ER, or IR. It is a general announcement that is not covered by the more specific codes (like M&A or CAP). Therefore, the most appropriate fallback category for a non-regulatory press release distributed via the RNS mechanism is Regulatory Filings (RNS), as it is the general distribution channel announcement.
2021-05-13 English
Sale of Shares and PDMR Shareholding
Director's Dealing Classification · 98% confidence The document is a notification released via RNS (Regulatory News Service) concerning a transaction by a Person Discharging Managerial Responsibilities (PDMR), specifically the Chief Commercial Officer selling shares. This type of insider transaction report is explicitly covered under 'Director's Dealing' (DIRS) in many regulatory frameworks (like MAR Article 19, referenced in the text). Although it is distributed via RNS, the core content is about insider trading, making 'DIRS' the most specific classification. However, looking at the provided definitions, 'DIRS' is defined as 'Report of personal share transactions by company directors and executives (insider trades)'. The document structure, including the RNS header and the explicit table detailing the transaction under 'Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014', confirms this is a Director's Dealing report. The document length is moderate (5309 chars), so it is the report itself, not just an announcement of a report.
2021-05-12 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is identified by the header 'RNS Number : 6924X' and contains the standard form 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification. The filing explicitly details the percentage of voting rights held (5.96%) and the date the threshold was crossed. Therefore, the correct classification is Major Shareholding Notification (MRQ).
2021-05-05 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.